Service de pharmacologie clinique

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


630 publications

... | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
2002
 
Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery
Marzolini C., Beguin A., Telenti A., Schreyer A., Buclin T., Biollaz J., Decosterd L. A., 2002/07. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 774 (2) pp. 127-40.
[DOI][WoS][Pmid][serval:BIB_FE146774859E]
 
Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitor-treated HIV-infected patients.
Doser N., Kübli S., Telenti A., Marzolini C., Chave J.P., Feihl F., Buclin T., Pannatier A., Darioli R., Nicod P. et al., 2002. AIDS, 16 (14) pp. 1982-3. Peer-reviewed.
[Pmid][serval:BIB_477361CA79FF]
 
Prévention et traitement de l'insuffisance rénale aiguë : rôle des traitements diurétiques
Livio F., 2002. Médecine et Hygiène, 60 (2387) pp. 727-730.
[serval:BIB_25706]
 
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.
Fellay J., Marzolini C., Meaden E.R., Back D.J., Buclin T., Chave J.P., Decosterd L.A., Furrer H., Opravil M., Pantaleo G. et al., 2002. The Lancet, 359 (9300) pp. 30-36. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_15EF32DDF0CC]
The 4,977-base pair common deletion of mitochondrial DNA is not associated with steatosis in chronic hepatitis C patients.
Latorre P., Rubbia-Brandt L., Giostra E., Abid K., Negro F., 2002/01. Hepatology, 35 (1) pp. 239-240. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F3376DC39EDE]
 
Transplacental passage of protease inhibitors at delivery.
Marzolini C., Rudin C., Decosterd L.A., Telenti A., Schreyer A., Biollaz J., Buclin T., 2002. AIDS, 16 (6) pp. 889-893. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_24752]
2001
Detection of the negative-strand hepatitis C virus RNA in tissues: implications for pathogenesis.
Quadri R., Rubbia-Brandt L., Abid K., Negro F., 2001/11. Antiviral research, 52 (2) pp. 161-171. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AADBCB852611]
 
Impaired absorption of rifabutin by concomitant administration of didanosine
Marzolini C., Chave J. P., Telenti A., Brenas-Chinchon L., Biollaz J., 2001/11. AIDS, 15 (16) pp. 2203-4.
[DOI][WoS][Pmid][serval:BIB_8EE75DE9A92B]
 
Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variability
Marzolini C., Buclin T., Decosterd L. A., Biollaz J., Telenti A., 2001/08. Therapeutic Drug Monitoring, 23 (4) pp. 394-8.
[DOI][WoS][Pmid][serval:BIB_AFB4A7406A45]
 
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.
Marzolini C., Telenti A., Decosterd L.A., Greub G., Biollaz J., Buclin T., 2001. AIDS, 15 (1) pp. 71-75. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_84CEAFA7373C]
 
Rate, type, and cost of adverse drug reactions in emergency department admissions.
Wasserfallen J., Livio F., Buclin T., Tillet L., Yersin B., Biollaz J., 2001. European Journal of Internal Medicine, 12 (5) pp. 442-447.
[Pmid][serval:BIB_91D3108BDEA5]
 
Rôle du suivi thérapeutique des concentrations d'antirétroviraux dans la prise en charge des patients HIV
Marzolini C., Décosterd L. A., Buclin T., Telenti A., Biollaz J., 2001. Médecine et Hygiène, 59 (2369) pp. 2302-2305.
[serval:BIB_9C38267673ED]
 
Wegener's granulomatosis: description of a case where cutaneous involvement was correlated with elevation of the c-ANCA titer
Mock M., Cerottini J. P., Derighetti M., Buxtorf K., Livio F., Panizzon R. G., 2001. Dermatology, 202 (4) pp. 347-9.
[DOI][WoS][Pmid][serval:BIB_D675E68240F7]
2000
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.
Rubbia-Brandt L., Quadri R., Abid K., Giostra E., Malé P.J., Mentha G., Spahr L., Zarski J.P., Borisch B., Hadengue A. et al., 2000/07. Journal of hepatology, 33 (1) pp. 106-115. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CA6AABC7CAE9]
A novel hepatitis C virus (HCV) subtype from Somalia and its classification into HCV clade 3.
Abid K., Quadri R., Veuthey A.L., Hadengue A., Negro F., 2000/06. The Journal of general virology, 81 (Pt 6) pp. 1485-1493. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_05E7BC554311]
Hepatitis C virus, the E2 envelope protein, and alpha-interferon resistance.
Abid K., Quadri R., Negro F., 2000/03/03. Science, 287 (5458) p. 1555. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3D029EC8CDF4]
 
Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction
Marzolini C., Telenti A., Buclin T., Biollaz J., Decosterd L. A., 2000/03. Journal of Chromatography. B, Biomedical Sciences and Applications, 740 (1) pp. 43-58.
[DOI][WoS][Pmid][serval:BIB_645EE36B1BB1]
 
Efavirenz decreases methadone blood concentrations.
Marzolini C., Troillet N., Telenti A., Baumann P., Decosterd L.A., Eap C.B., 2000. AIDS, 14 (9) pp. 1291-1292. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3264B6C2D4B7]
 
Intoxication au lithium
Livio F., Wauters J.P., 2000. Médecine et Hygiène, 58 (2289) pp. 426-430.
[serval:BIB_17128]
 
Les intoxications médicamenteuses volontaires
Buclin T., Livio F., Yersin B., Biollaz J., 2000. pp. 113-119 dans L'abus de médicaments en Suisse chap. 11, SFA-ISPA PRESS, Lausanne.
[serval:BIB_3C3BC36A8C98]
1999
Sequential administration of temozolomide and fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours
Gander M., Leyvraz S., Decosterd L., Bonfanti M., Marzolini C., Shen F., Lienard D., Perey L., Colella G., Biollaz J. et al., 1999/07. Annals of Oncology, 10 (7) pp. 831-8.
[URN][DOI][WoS][Pmid][serval:BIB_6B773617CF43]
 
Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers.
Rothuizen L.E., Buclin T., Spertini F., Trinchard I., Munafo A., Buchwalder P.A., Ythier A., Biollaz J., 1999. Journal of Neuroimmunology, 99 (1) pp. 131-141.
[DOI][WoS][Pmid][serval:BIB_A108268603FA]
1998
 
Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration.
Marzolini C., Decosterd L.A., Shen F., Gander M., Leyvraz S., Bauer J., Buclin T., Biollaz J., Lejeune F., 1998. Cancer Chemotherapy and Pharmacology, 42 (6) pp. 433-440.
[DOI][WoS][Pmid][serval:BIB_7BB2FAA8F76D]
1997
 
Influence du contenu en résidus acides de la diète sur le métabolisme et l’excrétion du calcium
Cosma M., Buclin T., Appenzeller M., Jacquet A. F., Biollaz J., Burckhardt P., 1997. Schweizerische Medizinische Wochenschrift, S88 pp. 34S.
[serval:BIB_375498E69BF8]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University